Investing Profile

Klaus Breiner

InvestorVCFounder
Managing Partner at Pureos Bioventures
pureosbio.comSwitzerland
Photo of Klaus Breiner, Managing Partner at Pureos Bioventures
Your Intro Paths to Klaus Breiner

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Klaus is a member of
University of North Carolina at Chapel Hill Network
95 CONNECTIONS
Booz Allen Hamilton Network
78 CONNECTIONS
Heidelberg University Network
17 CONNECTIONS
Ruprecht-Karls-Universität Heidelberg Network
11 CONNECTIONS

Find Klaus Breiner on

cb
Current Investing Position
Pureos Bioventures Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
5
Current Fund Size
$205M

Klaus Breiner is on these Sector & Stage Rankings

Klaus Breiner's Investments On Record (4)

CompanyStageDateRound SizeTotal Raised
Tridek-One
Series UnknownSep 2022$16M
$16M
Co-investors: Alain Huriez (AdBio partners)
ImCheck Therapeutics
Series CJun 2022$100M
Series BSep 2020$7M
$180M
Co-investors: Rémi Droller (Financial Services, Financial Technology, and Business Services), Vincent Brichard (EQT Group), Michael Baran (Pfizer Venture Investments), Dr. Regina Hodits (Wellington Partners), Raphael Wisniewski (Andera Partners), Florent Gros (Earlybird Venture Capital)
Natural Dental Implants
Series AJun 2014$1M
$1M
Vaximm
Series UnknownJan 2011$8M
$8M

Klaus Breiner's Experience

Co-founder and Managing Director Pureos Partners AG2021 - Present
Non-executive Director VICO Therapeutics B.V.2021 - Present
Managing Partner Pureos Bioventures2017 - Present
Partner BB Biotech Ventures2004 - Present
Post-doctoral Fellow ETHZPresent
Board Director ZMBH - Universität HeidelbergPresent
Senior Adviser Private Equity Bellevue Asset ManagementPresent
Board Director AbyrxPresent
Non-executive Director Vico TherapeuticsPresent
Partner ZMBH - Universität HeidelbergPresent
Co-founder and Managing Director ZMBH - Universität HeidelbergPresent
Co-Founder & Vice-Chairman (Executive Chairman till mid-2016) Vaximm AG2008 - 2022
Board Director ORTHOCON2006 - 2021
Senior Adviser Private Equity Bellevue2004 - 2021
Board Director Alpex Pharma SA2007 - 2020
Board Director AM-Pharma2011 - 2019
Board Director Pevion Biotech AG2007 - 2011
Investment Manager Global Life Science Ventures2001 - 2004
Board Director Glycart Biotechnology AG2003 - 2004
Associate Booz Allen Hamilton2000 - 2001
Post-doctoral Fellow ETH Zurich1999 - 2000
Post-doctoral Fellow ZMBH - Universität Heidelberg1998 - 1999
Research Associate ZMBH - Universität Heidelberg1995 - 1998

Klaus Breiner's Education

Ruprecht-Karls-Universität Heidelberg / University of Heidelberg Ph.D. (Dr.rer.nat.) Biochemistry and Molecular Biology
University of North Carolina at Chapel Hill Master of Arts (M.A.) Chemistry
Heinrich-Heine-Universität Düsseldorf Chemistry
Fernuniversität Hagen Business Administration & Economics
Fachhochschule Aachen Diplom Ingenieur Chemical Engineering
FH Aachen University of Applied Sciences Diplom Ingenieur Chemical Engineering
The University of North Carolina at Chapel Hill Master of Arts (M.A.) Chemistry
Ruprecht-Karls-Universität Heidelberg Ph.D. (Dr.rer.nat.) Biochemistry and Molecular Biology
Heidelberg University Ph.D. (Dr.rer.nat.) Biochemistry and Molecular Biology

Investors who invest with Klaus Breiner

Sign in with Google →

Scouts & Angels Affiliated With Klaus Breiner

Sign in with Google →